Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Latest Articles

  • You have access
    A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient KV11.1 (hERG) Variants
    Christian L. Egly, Daniel J. Blackwell, Jeffrey Schmeckpeper, Brian P. Delisle, C. David Weaver and Björn C. Knollmann
    Molecular Pharmacology April 2022, 101 (4) 236-245; DOI: https://doi.org/10.1124/molpharm.121.000421
  • You have access
    mTOR Regulation of AGC Kinases: New Twist to an Old Tail
    Timothy R. Baffi and Alexandra C. Newton
    Molecular Pharmacology April 2022, 101 (4) 213-218; DOI: https://doi.org/10.1124/molpharm.121.000310
  • You have access
    The Tails of Protein Kinase A
    Susan S. Taylor, Kristoffer Søberg, Evan Kobori, Jian Wu, Sabine Pautz, Friedrich W. Herberg and Bjørn Steen Skålhegg
    Molecular Pharmacology April 2022, 101 (4) 219-225; DOI: https://doi.org/10.1124/molpharm.121.000315
  • You have access
    CCT and CCT-Like Modular Protein Interaction Domains in WNK Signaling
    Clinton A. Taylor and Melanie H. Cobb
    Molecular Pharmacology April 2022, 101 (4) 201-212; DOI: https://doi.org/10.1124/molpharm.121.000307
  • You have access
    A Recombinant Dimethylarginine Dimethylaminohydrolase-1–Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity
    Young Lee, Jaipal Singh, Susan R. Scott, Bradley Ellis, Pinar Zorlutuna and Meijing Wang
    Molecular Pharmacology April 2022, 101 (4) 226-235; DOI: https://doi.org/10.1124/molpharm.121.000394
  • Yeast <em>β</em>-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
    You have access
    Yeast β-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
    Ferbian Milas Siswanto, Akiyoshi Tamura, Rika Sakuma and Susumu Imaoka
    Molecular Pharmacology April 2022, 101 (4) 257-273; DOI: https://doi.org/10.1124/molpharm.121.000475
  • You have access
    Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors
    Jon Merlin, Julia Park, Teresa H. Vandekolk, Stewart A. Fabb, Jeanne Allinne, Roger J. Summers, Christopher J. Langmead and Darren M. Riddy
    Molecular Pharmacology April 2022, 101 (4) 246-256; DOI: https://doi.org/10.1124/molpharm.121.000422
  • You have access
    Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin
    Fereshteh Ahmadinejad, Tasia Bos, Bin Hu, Erin Britt, Jennifer Koblinski, Andrew J. Souers, Joel D. Leverson, Anthony C. Faber, David A. Gewirtz and Hisashi Harada
    Molecular Pharmacology March 2022, 101 (3) 168-180; DOI: https://doi.org/10.1124/molpharm.121.000354
  • You have access
    Roles of Receptor Phosphorylation and Rab Proteins in G Protein-Coupled Receptor Function and Trafficking
    Juan Carlos Martínez-Morales, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and Jesús Adolfo García-Sáinz
    Molecular Pharmacology March 2022, 101 (3) 144-153; DOI: https://doi.org/10.1124/molpharm.121.000429
  • You have access
    Cholesterol Inhibition of Slo1 Channels Is Calcium-Dependent and Can Be Mediated by Either High-Affinity Calcium-Sensing Site in the Slo1 Cytosolic Tail
    Kelsey C. North, Man Zhang, Aditya K. Singh, Dasha Zaytseva, Alexandria V. Slayden, Anna N. Bukiya and Alex M. Dopico
    Molecular Pharmacology March 2022, 101 (3) 132-143; DOI: https://doi.org/10.1124/molpharm.121.000392

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 1211
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics